Clinical Trials Directory

Trials / Terminated

TerminatedNCT03624608

Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures

Evaluation of the Auryzon Family of Cartilage Processing Devices in the Optimization of Cartilaginous Reconstructions

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Reconstrata, LLC · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study evaluates the efficacy of the AuryzoN devices in the ear and nose reconstruction surgeries, both in terms of operative time and overall quality of reconstruction. Research participants will undergo reconstruction either using the AuryzoN device or through current methods (traditional manual processing) at the discretion of their surgeon prior to the start of surgery.

Detailed description

The AuryzoN devices are a family of two (2) devices that, in conjunction, serve to process substrates of autologous-derived or cadaveric cartilage used in the reconstruction of various structures of the body, namely ear and nose. The devices are to be used in the operating room to cut and carve substrates of tissue into components, which are then assembled into the final ear or nose, that will then be implanted by the plastic surgeon into the appropriate area. This device family serves to replace the current step in this reconstructive procedure, which involves the time-consuming and error-prone process of manual cartilage processing. Participants will be given the option to participate in the study. If the participants so choose, they will undergo ear or nose reconstruction using the AuryzoN devices or traditional manual processing at the discretion of their surgeon prior to the start of surgery. The following outcome measures will be measured: operative time, error rates, objective quality outcomes of reconstruction, subjective quality outcomes of reconstruction, and patient satisfaction.

Conditions

Interventions

TypeNameDescription
DEVICEAuryzoN Family of DevicesThe AuryzoN family of devices includes a longitudinal cartilage trimmer (DimensioN) and 2D shape carving machine with custom blades (AuryzoN).

Timeline

Start date
2020-03-01
Primary completion
2025-01-20
Completion
2025-01-20
First posted
2018-08-10
Last updated
2025-01-23

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03624608. Inclusion in this directory is not an endorsement.